|
|
|
|
|
| |
Par Pharmaceutical Net Surges |
|
| |
9:00 AM EDT May 01 2006 |
|
|
| |
Par Pharmaceutical Cos, manufacturer of generic drugs, reported Q1 net income of 24 cents a share, up from 6 cents, earned in the same period a year ago on revenue growth. The company met analysts’ forecasts for earnings of 24 cents a share. Par Pharma's growth came even as it continued to make investments in building an organization around its first branded product, Megace ES. |
|
|
| |
|
|
|
|
